iHuman (IH) Competitors $2.82 +0.02 (+0.86%) Closing price 08/8/2025 03:58 PM EasternExtended Trading$2.74 -0.08 (-2.80%) As of 08/8/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IH vs. QSG, VSTA, EM, NRDY, EWCZ, SDA, COE, CHGG, HCMA, and STGShould you be buying iHuman stock or one of its competitors? The main competitors of iHuman include QuantaSing Group (QSG), Vasta Platform (VSTA), Smart Share Global (EM), Nerdy (NRDY), European Wax Center (EWCZ), SunCar Technology Group (SDA), 51Talk Online Education Group (COE), Chegg (CHGG), HCM Acquisition (HCMA), and Sunlands Technology Group (STG). These companies are all part of the "personal services" industry. iHuman vs. Its Competitors QuantaSing Group Vasta Platform Smart Share Global Nerdy European Wax Center SunCar Technology Group 51Talk Online Education Group Chegg HCM Acquisition Sunlands Technology Group QuantaSing Group (NASDAQ:QSG) and iHuman (NYSE:IH) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings. Does the media refer more to QSG or IH? In the previous week, iHuman had 1 more articles in the media than QuantaSing Group. MarketBeat recorded 2 mentions for iHuman and 1 mentions for QuantaSing Group. QuantaSing Group's average media sentiment score of 1.91 beat iHuman's score of 0.00 indicating that QuantaSing Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuantaSing Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive iHuman 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings & valuation, QSG or IH? QuantaSing Group has higher revenue and earnings than iHuman. QuantaSing Group is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuantaSing Group$522.26M0.78$53.05M$1.117.21iHuman$126.34M1.16$13.51M$0.2710.46 Do insiders and institutionals believe in QSG or IH? 4.9% of iHuman shares are owned by institutional investors. 63.6% of iHuman shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend QSG or IH? QuantaSing Group currently has a consensus target price of $9.52, indicating a potential upside of 19.00%. Given QuantaSing Group's stronger consensus rating and higher probable upside, equities analysts clearly believe QuantaSing Group is more favorable than iHuman.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QuantaSing Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00iHuman 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, QSG or IH? QuantaSing Group has a beta of -0.98, suggesting that its share price is 198% less volatile than the S&P 500. Comparatively, iHuman has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Is QSG or IH more profitable? QuantaSing Group has a net margin of 14.27% compared to iHuman's net margin of 11.44%. QuantaSing Group's return on equity of 68.92% beat iHuman's return on equity.Company Net Margins Return on Equity Return on Assets QuantaSing Group14.27% 68.92% 28.97% iHuman 11.44%11.00%7.38% SummaryQuantaSing Group beats iHuman on 10 of the 16 factors compared between the two stocks. Get iHuman News Delivered to You Automatically Sign up to receive the latest news and ratings for IH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IH vs. The Competition Export to ExcelMetriciHumanSCHOOLS IndustryDiscretionary SectorNYSE ExchangeMarket Cap$145.65M$1.64B$8.08B$20.71BDividend YieldN/A4.59%3.23%3.65%P/E Ratio10.4612.7618.9528.06Price / Sales1.161.904.7055.98Price / Cash9.4714.5514.3217.60Price / Book1.122.864.804.61Net Income$13.51M$85.04M$227.90M$994.05M7 Day Performance-4.59%5.54%2.95%1.97%1 Month Performance24.46%1.02%-2.85%-1.60%1 Year Performance83.38%38.29%20.03%14.32% iHuman Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IHiHuman1.1391 of 5 stars$2.82+0.9%N/A+83.4%$145.65M$126.34M10.461,120News CoverageQSGQuantaSing Group2.2678 of 5 stars$8.33+4.4%$9.52+14.3%+373.4%$408.67M$3.11B7.502,010News CoveragePositive NewsShort Interest ↑VSTAVasta Platform3.6428 of 5 stars$4.22-0.2%N/A+41.8%$339.26M$310.48M4.181,808News CoverageEarnings ReportAnalyst ForecastEMSmart Share Global1.4311 of 5 stars$1.18+1.7%$1.25+5.9%+65.9%$294.11M$1.89B39.355,090Positive NewsNRDYNerdy2.1101 of 5 stars$1.48+3.1%$2.31+56.8%+57.0%$260.90M$190.23M-3.69700News CoverageEarnings ReportAnalyst ForecastGap DownEWCZEuropean Wax Center3.6711 of 5 stars$4.30+1.9%$7.00+62.8%-42.3%$232.97M$216.92M21.50110News CoverageUpcoming EarningsAnalyst ForecastSDASunCar Technology Group3.7129 of 5 stars$2.24+2.3%$7.75+246.0%-75.5%$226.97M$441.90M0.00N/ACOE51Talk Online Education GroupN/A$31.78+4.2%N/A+147.8%$185.82M$59.49M-17.75620CHGGChegg3.7476 of 5 stars$1.40+10.7%$1.70+21.9%-45.7%$134.28M$617.57M-0.171,271Gap UpHCMAHCM AcquisitionN/A$7.42+0.3%N/A-9.0%$104.93MN/A0.00N/AGap DownSTGSunlands Technology Group1.556 of 5 stars$8.35+10.4%N/A-7.2%$102.20M$272.66M2.682,071News CoveragePositive NewsUpcoming EarningsShort Interest ↑Gap Up Related Companies and Tools Related Companies QuantaSing Group Alternatives Vasta Platform Alternatives Smart Share Global Alternatives Nerdy Alternatives European Wax Center Alternatives SunCar Technology Group Alternatives 51Talk Online Education Group Alternatives Chegg Alternatives HCM Acquisition Alternatives Sunlands Technology Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IH) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iHuman Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share iHuman With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.